It’s three quarters in and digital health venture funding in 2013 has already surpassed what it was in 2012.
So far this year, investors have packed $1.5 billion into digital health companies through 145 deals, according to calculations by Rock Health. Just last quarter, the amount totaled $673 million, a 37 percent spike from the same quarter last year. And some of those deals have been pretty big.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Big data firm Ayasdi raised its second round this year, bringing in $30.6 million.
Practice Fusion raised a $70 million Series D.
Withings brought in $30 million to expand internationally.
A subsidiary of the largest insurer in Florida led a $20 million round for Audax Health.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Population health management company ZeOmega raised $21.5 million.
Fitbit nabbed $43 million from investors.
And, most recently, Evolent raised $100 million for tools that help health systems run insurance plans.
Rock Health only includes rounds bigger than $2 million that involve a venture investor in its tabulations, so the total overall funding for digital health companies would be even more including seed and angel rounds and grant funding.
A few recent reports have suggested that the growth of investment might slow down as the digital health sector matures and begins to see more exits. So far, though, that doesn’t seem to be the case.
[Chart from Rock Health]
